Erlotinib-induced bullous pemphigoid

J Am Acad Dermatol. 2012 Nov;67(5):e199-201. doi: 10.1016/j.jaad.2012.01.034.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / pathology
  • Aged
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Brain Neoplasms / secondary
  • ErbB Receptors / antagonists & inhibitors*
  • Erlotinib Hydrochloride
  • Fatal Outcome
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / pathology
  • Male
  • Pemphigoid, Bullous / chemically induced*
  • Pemphigoid, Bullous / pathology
  • Quinazolines / adverse effects*
  • Quinazolines / therapeutic use

Substances

  • Antineoplastic Agents
  • Quinazolines
  • Erlotinib Hydrochloride
  • ErbB Receptors